| Unique ID issued by UMIN | UMIN000059999 |
|---|---|
| Receipt number | R000068616 |
| Scientific Title | Development and Clinical Evaluation of a Gluteus Medius Assistive Device for Abnormal Gait Correction |
| Date of disclosure of the study information | 2025/12/05 |
| Last modified on | 2025/12/05 16:10:28 |
Development and Clinical Evaluation of a Gluteus Medius Assistive Device for Abnormal Gait Correction
Development and Clinical Evaluation of a Gluteus Medius Assistive Device for Abnormal Gait Correction
Development and Clinical Evaluation of a Gluteus Medius Assistive Device for Abnormal Gait Correction
Development and Clinical Evaluation of a Gluteus Medius Assistive Device for Abnormal Gait Correction
| Japan |
-Knee osteoarthritis
-Trendelenburg gait
| Orthopedics | Rehabilitation medicine |
Others
NO
Verification of the Gait-Correction Effect of an Assistive Motion Device
Efficacy
- Lateral knee acceleration
- Gait data
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
| Device,equipment |
Participants will walk for 10 minutes at a unified walking cadence of 100 bpm while wearing the device. The examiner will give the start and stop instructions, and lateral knee acceleration, pelvic frontal plane inclination angle, and other gait data will be continuously recorded during walking. The assistive mechanism of the device will operate in the normal support mode, and the intervention will be conducted while ensuring safety at all times.
| 20 | years-old | <= |
| 85 | years-old | >= |
Male and Female
- Individuals who request to participate in training using the motion-assist orthosis, have been diagnosed with an abnormal gait, require the use of a corrective orthosis, and are deemed eligible for participation by both the attending physician and the physical therapist.
- Healthy older adults who request to participate in training using the motion-assist orthosis.
1. Uncontrolled heart failure
2. Acute myocardial infarction
3. Active myocarditis or pericarditis
4. Unstable angina
5. Acute systemic embolism or pulmonary embolism
6. Acute infectious disease
7. Thrombophlebitis
8. Ventricular tachycardia or refractory ventricular arrhythmia
9. Severe left ventricular outflow tract obstruction
10. Uncontrolled arterial hypertension or pulmonary hypertension
11. Participation in another interventional study during the same period (to be verbally confirmed with the responsible physical therapist)
* The exclusion criteria will be determined by the attending physician.
48
| 1st name | Hiroyasu |
| Middle name | |
| Last name | Iwata |
Waseda University
Faculty science and engineering
162-0042
27 Waseda-machi, Shinjuku-ku, Tokyo 162-0044, Japan Green Computing Systems Reserch Organization 603 Prof. Iwata Lab.
03-3203-4427
jubi@waseda.jp
| 1st name | Hiroyasu |
| Middle name | |
| Last name | Iwata |
Waseda University
Faculty science and engineering
162-0042
27 Waseda-machi, Shinjuku-ku, Tokyo 162-0044, Japan Green Computing Systems Reserch Organization 603
03-3203-4427
jubi@waseda.jp
Waseda University
Waseda University
Other
Yokohama Seishinkai Hospital
Waseda University Institutional Review Board
2nd Floor, Building 9, 1-104 Totsuka-machi, Shinjuku-ku, Tokyo
03-5272-1639
rinri@list.waseda.jp
NO
横浜石心会病院(神奈川県)
| 2025 | Year | 12 | Month | 05 | Day |
Unpublished
Preinitiation
| 2025 | Year | 12 | Month | 05 | Day |
| 2026 | Year | 02 | Month | 01 | Day |
| 2030 | Year | 03 | Month | 31 | Day |
| 2025 | Year | 12 | Month | 05 | Day |
| 2025 | Year | 12 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068616